NEON THERAPEUTICS, INC. Financing Cash Flow
NEON THERAPEUTICS, INC. reported Financing Cash Flow of -$59.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2020-05-01
- NEON THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2020-03-31 was -$59.00K, a 231.11% decline year-over-year.
- NEON THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-12-31 was $397.00K.
- NEON THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-09-30 was $68.00K.
- NEON THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- NEON THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2019 was $510.00K, a 99.44% decline from fiscal 2018.
- NEON THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2018 was $90.34M, a 151.57% increase from fiscal 2017.
- NEON THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2017 was $35.91M, a 67.68% decline from fiscal 2016.
- NEON THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2016 was $111.12M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$59.00K 10-Q · filed 2020-05-01 | $338.00K derived: sum of 2 quarters · filed 2020-05-01 | $406.00K derived: sum of 3 quarters · filed 2020-05-01 | $406.00K derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $465.00K derived: sum of 2 quarters · filed 2020-03-02 | $465.00K derived: sum of 3 quarters · filed 2020-03-02 | $510.00K 10-K · filed 2020-03-02 |
| 2019-09-30 | $68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $68.00K derived: sum of 2 quarters · filed 2019-11-12 | $113.00K 10-Q · filed 2019-11-12 | $83.00K derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $45.00K 10-Q · filed 2019-08-06 | $15.00K derived: sum of 3 quarters · filed 2020-05-01 | -$538.00K derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-03-31 | $45.00K 10-Q · filed 2020-05-01 | $15.00K derived: sum of 2 quarters · filed 2020-05-01 | -$538.00K derived: sum of 3 quarters · filed 2020-05-01 | $91.47M derived: sum of 4 quarters · filed 2020-05-01 |
| 2018-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$583.00K derived: sum of 2 quarters · filed 2020-03-02 | $91.43M derived: sum of 3 quarters · filed 2020-03-02 | $90.34M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$553.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $91.46M derived: sum of 2 quarters · filed 2019-11-12 | $90.37M 10-Q · filed 2019-11-12 | $126.22M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $92.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $90.92M 10-Q · filed 2019-08-06 | $126.78M derived: sum of 3 quarters · filed 2019-08-06 | $126.78M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$1.09M 10-Q · filed 2019-05-13 | $34.76M derived: sum of 2 quarters · filed 2019-05-13 | $34.77M derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | $35.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $35.86M derived: sum of 2 quarters · filed 2019-03-11 | $35.91M 10-K · filed 2019-03-11 | |
| 2017-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $55.00K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $50.00K 10-Q · filed 2018-08-06 | |||
| 2016-12-31 | $111.12M 10-K · filed 2019-03-11 |